Researches of Retinal Artery Lesions and Acute Coronary Syndrome (REACS)
Retinal Artery Lesions to Predict Long-term Outcomes in Patients With Acute Coronary Syndrome After Drug-Eluting Stent Implantation
Sponsor: Beijing Haidian Hospital
Listed as NCT02415452, this observational or N/A phase trial focuses on Acute Coronary Syndrome and remains ongoing. Sponsored by Beijing Haidian Hospital, it has been updated 8 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Active Not Recruiting NA
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Haidian Hospital
- Beijing Mentougou District Hospital
- Beijing Shijitan Hospital, Capital Medical University
- Capital Medical University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.